表紙
市場調査レポート

世界の治療用ワクチン市場:動向および予測

Global Therapeutic Vaccines Market- Trends And Forecasts (2015-2020)

発行 Mordor Intelligence LLP 商品コード 319400
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
世界の治療用ワクチン市場:動向および予測 Global Therapeutic Vaccines Market- Trends And Forecasts (2015-2020)
出版日: 2016年01月01日 ページ情報: 英文
概要

ワクチン市場は世界の医薬品市場売上のわずか2〜3%ですが、近年急速に発展しており、2000年の50億米ドルから2013年には240億米ドルに拡大しています。今後も2020年にかけCAGR12.4%で拡大すると予測されています。

当レポートでは、世界の治療用ワクチン市場の動向とワクチンの概要、用途別、地域別動向、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界の治療用タンパク質市場:業界分析

  • 市場促進因子
    • 需要拡大、発症率の上昇
    • 政府支援のプロジェクトや援助
    • 収益性の高さと技術改良
  • 市場の機会
    • 新たな標的となる人口:先進国から途上国への移行
  • 市場阻害因子
  • 悪影響リスク

第4章 ワクチンの種類

  • 生ワクチン、弱毒化ワクチン
  • 不活性化ワクチン
  • サブユニットワクチン
  • トキソイドワクチン
  • 共役ワクチン
  • DNAワクチン
  • 組換えベクターワクチン

第5章 用途別ワクチン市場(市場規模、予測、CAGR)

  • 小児用ワクチン
  • 成人用ワクチン

第6章 ワクチン市場の地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 競合環境

  • ワクチンに関する現在の市場動向
  • ワクチンの将来
  • 合弁
  • 合併・買収
  • PenAct HIB、Quinvaxem、5価ワクチンの将来

第8章 企業プロファイル

  • Sanofi Avnetis
  • Merck
  • Glaxosmithkline
  • Novartis
  • Pfizer
  • Serum institute

第9章 表リスト

第10章 図リスト

第11章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Global market for Therapeutic vaccines is expected to reach $4.82 billion by the end of 2020 growing at a CAGR of around 33.6% from $ 1.15 Billion in 2015. Several new approaches are being developed in order to boost the immune response to the cancerous cells.These technical advancements are expected to add powerful new components to the standard cancer treatments.In the pipeline, therapeutic vaccines are also in development to treat infectious diseases such as the Human Immunodeficiency Virus (HIV), neurological disorders such as Alzheimers disease, autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, and other conditions such as hypertension.

The Global Therapeutic Vaccines Market is segregated on the basis of Autoimmune Disease Vaccines (Type I Diabetes), Neurological Disease Vaccines (CAD106, ACC-001, Alzheimer's Disease, Parkinsons Disease Vaccine and Other Disease Vaccines), Cancer Vaccines (TroVax, PR1 Peptide Vaccine, Multikine, CYT004-MelQbG10 etc..), and Infectious Disease Vaccines (HIV/AIDS, Hepatitis C, and Other Infectious Disease Vaccines) & Region (North America, Europe, Asia Pacific & Rest of the World).

Drivers

The Favorable government funding for vaccine development, increasing investments by the companies Technological advancements, rising prevalence of disease are the major factors that are driving the market growth.

Challenges

Huge capital expenditures and Stringent Regulatory policies are hindering the market growth.

What the report offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Therapeutic vaccines Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Therapeutic vaccines Market in Healthcare Industry on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

  • Introduction
  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period years
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions
  • Executive Summary
  • Key Inferences
  • Market Overview and Industry trends
  • Current Market Senario
  • Newborn Screening test Applications
  • Technology Overview
  • New Developments
  • Industry Value chain analysis
  • product Life cycle analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat to new entrants
  • Threat to substitute products and services
  • Competitive Rivalry within the industry
  • Drivers, Restraints, Opportunities, and challenges Analysis
  • Market Drivers
  • Favorable government funding for vaccine development
  • Increasing investments by the companies
  • Technological advancements
  • Rising Prevalences of Disease
  • Market Restraints
  • Huge capital expenditures
  • Stringent Regulatory Polices
  • Global Therapeutic Vaccines Market segmentation
  • Introduction
  • Segmentation by product type
  • Autoimmune Disease Vaccines
  • Tovaxin
  • Diamyd( rhGAD65)
  • BHT-3021
  • Neurological Disease Vaccines
  • CAD106
  • ACC-001
  • Alzhiemer's Disease
  • Parkinson's Disease
  • Others
  • Cancer Vaccines
  • TroVax
  • PR1 Peptide Vaccine
  • Multikine
  • CYT004-MelQbG10
  • BLP25 Liposome vaccine
  • HyperAcute Melanoma
  • Provenge (APC8015, Sipuleucel-T)
  • Allovectin-7
  • GRNVAC1
  • ProstVac
  • Belagenpumatucel-L (Lucanix)
  • GSK1572932A
  • MelCancerVac
  • Abagovomab
  • DCVax-Brain
  • JX-594
  • GSK2132231A
  • "GI-4000
  • "
  • HyperAcute-Pancreas
  • TG4001/R3484 (MVA-HPV-IL2)
  • HyperAcute-Lung
  • PEP223
  • AGS-003
  • Glionix
  • AE37
  • NeuVax (E75)
  • "Onyvax-P (ONY-P1)
  • "
  • TG4010 (MVA-MUC1-IL2)
  • CDX-110 (PF-04948568)
  • GV1001
  • CB-10-01
  • MyVax
  • Biovaxid
  • Infectious Disease Vaccine
  • HIV/AIDS
  • Hepatitis C
  • Others
  • Market segmentation by Geography
  • North America
  • Introduction
  • United States
  • Canada
  • Mexico
  • Europe
  • Introduction
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Scandinavia
  • BENELUX
  • Rest of Europe
  • Asia-Pacific (APAC)
  • Introduction
  • China
  • Japan
  • India
  • Australia and New Zealand
  • South Korea
  • Rest of Asia Pacific
  • Middle-East and North Africa
  • Introduction
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of Middle-east & Africa
  • South America
  • Introduction
  • Brazil
  • Argentina
  • Rest of Latin America
  • Competitive Landscape
  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Parterships
  • Key Vendor Analysis
  • Antigenics
  • Bavarian Nordic
  • Celtic Pharma
  • Curevac
  • Cytos Biotechnology
  • GlaxoSmithKline
  • Pfizer
  • Merck Kgaa (Merck Serono)
  • Novartis
  • Transgene
  • Vaccinogen
  • Others
  • Analyst outlook for Investment opportunities
  • Future Outlook of the market
Back to Top